ARTICLE | Finance
Asset renaissance
How Medicxi increases Phase II successes with less capital
February 8, 2016 8:00 AM UTC
The former life sciences team from Index Ventures has set up shop as Medicxi Ventures with a heavily oversubscribed new fund, and an investment model that has so far scored it a 100% success rate in Phase II readouts while halving the capital needed to get there.
Medicxi is taking with it the 12-person life sciences team from Index, the remaining capital from the almost fully invested Index Ventures Life VI fund, and a portfolio of about 40 life sciences companies...